Relistor and Clindamycin hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relistor (methylnaltrexone bromide) and Clindamycin hydrochloride (clindamycin hydrochloride). Common drug interactions include atrial fibrillation among females.

The phase IV clinical study analyzes what interactions people have when they take Relistor and Clindamycin hydrochloride. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Relistor?

Relistor has active ingredients of methylnaltrexone bromide. eHealthMe is studying from 1,659 Relistor users. Check the latest studies of Relistor.

What is Clindamycin hydrochloride?

Clindamycin hydrochloride has active ingredients of clindamycin hydrochloride. It is often used in tooth abscess. eHealthMe is studying from 4,257 Clindamycin hydrochloride users. Check the latest studies of Clindamycin hydrochloride.



On Jul, 15, 2026

15 people who take Relistor and Clindamycin hydrochloride together, and have interactions are studied.

Relistor and Clindamycin hydrochloride drug interactions.

What are the common drug interactions of Relistor and Clindamycin Hydrochloride, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Juvenile myoclonic epilepsy (childhood epilepsy occurring early in morning affecting 12 to 18 years)
  3. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  4. Drug ineffective
  5. Vomiting
  6. Cardiac arrest
  7. Blood pressure increased
  8. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

male:

n/a

What are the common drug interactions of Relistor and Clindamycin Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Juvenile myoclonic epilepsy (childhood epilepsy occurring early in morning affecting 12 to 18 years)
  3. Loss of consciousness
  4. Heart rate increased
  5. Hospitalisation
  6. Cardiac arrest
  7. Blood pressure increased
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 100.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 100.00%
  3. Cystitis Interstitial (unknown cause characterized by bladder pain): 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Relistor and Clindamycin hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relistor and Clindamycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relistor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clindamycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relistor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clindamycin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylnaltrexone bromide and clindamycin hydrochloride (the active ingredients of Relistor and Clindamycin hydrochloride, respectively), and Relistor and Clindamycin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: